Volume 7, Number 5—October 2001
Research
Multidrug-Resistant Tuberculosis in Prison Inmates, Azerbaijan
Table
Characteristics of the cohort of prison inmates with tuberculosis, Azerbaijan
Strain no. | Age of patient (years) | Body mass index | Patient groupa | Onset of symptoms | Previous treatment (before enrollment in ICRC program)b |
---|---|---|---|---|---|
7933 | 25 | 18.2 | A | Aug 1996 | R,E,S |
7887 | 40 | -- | A | Jan 1995 | H,R,E,S |
7909 | 40 | 16.1 | A | Jun 1995 | S (4 mo. in 1995) S (1 mo. in 1996) |
7920 | 22 | 16.3 | A | Mar 1995 | H(?),R(?),S |
5695 | 22 | 17.2 | B | Feb 1996 | S |
5698 | 43 | -- | A | 1976 | R,E |
7101 | 20 | -- | B | Jan 1996 | S |
5691 | 26 | -- | A | Feb 1995 | S |
7915 | 21 | 16.2 | B | Mar 1996 | None |
7922 | 33 | 16.1 | A | Spring 1996 | H,R,E,S |
5689 | 24 | 19.7 | A | 1993 | H,R,E,S (1 to 2 mo.) |
7924 | 40 | 17.4 | B | Apr 1996 | H,R,E,S |
7934 | 36 | --c | A | Jul 1996 | S |
7908 | 32 | 16.1 | B | Mar 1996 | R,E,S |
7930 | 21 | 16 | B | Aug 1996 | R,E,S |
7935 | 23 | 17.3 | B | Mar 1996 | R |
7925 | 22 | 19.3 | A | Feb 1996 | S (monotherapy initially); R,E,S (2 to 3 mo.) |
7931 | 21 | 16 | B | Jul 1996 | R,S |
7914 | 34 | 15.7 | A | Nov 1995 | R,E,S (not completed) |
5713 | 25 | 15.6 | B | Dec 1995 | H,R,E,S |
7910 | 32 | 17.5 | A | Feb 1996 | S,E (not completed) |
7906 | 22 | 19.5 | B | Aug 1996 | R,S |
5719 | 32 | -- | C | 1991 | H,R,E,S (9 mo. in 1991) |
7923 | 34 | 13.8 | B | Jan 1996 | R,E,S |
7899 | 33 | 15.8 | A | Jan 1996 | H (4 mo.), R (10 d), E (4 mo.), S,Z (4 mo.) (not completed) |
5684 | 29 | 17.2 | A | 1993 | H,R,E,S (in 1994) S (in 1995) |
7900 | ? | 20.2 | A | Jul 1995 | H,R,S (in 1995) S (in 1996) |
5697 | 19 | 17.4 | B | Mar 1996 | none |
5692 | 22 | -- | A | Feb 1995 | H,R,E,S |
7916 | 32 | 18.2 | A | 1994 | H,R,E,S,K (several <3-mo.-intervals of treatment) |
7932 | 22 | 18.1 | C | Nov 1993 | H,R,E,S,K (several intervals of treatment: 1 mo., 4 mo., 12 mo.) |
5700 | 34 | 18 | B | Feb 1996 | none |
5702 | 26 | 18.1 | A | Sep 1995 | S |
5706 | 23 | -- | B | Feb 1996 | S |
5716 | 24 | 19 | B | Feb 1996 | R,S |
7888 | 30 | -- | A | Oct 1994 | H,R,E,K (<2 mo. in 1994) H,R (in 1995) |
5705 | 27 | -- | B | Sep 1995 | None |
5693 | 26 | 17.2 | B | Jan 1996 | S |
5722 | 26 | 17.1 | B | Dec 1995 | H,R,E,S,K |
7895 | 19 | 18.5 | B | Jun 1996 | H,R,S |
5724 | 37 | 17.3 | B | Dec 1995 | H,R,E,S |
7886 | 46c | -- | A | Mar 1995 | R,E,S (not completed) |
7917 | 55 | -- | C | 1987 | R,E,S (11 mo.) |
5718 | 20 | 17.6 | B | Oct 1995 | H,K |
7889 | ? | -- | A | ? | ? |
7921 | 22 | 19.4 | B | Jul 1996 | S |
7926 | 20 | --c | B | Aug 1996 | none |
7918 | 33 | 16.4 | B | Jul 1996 | H,R,E,S |
7927 | 32 | 18.4 | A | Mar 1996 | H,E,S (not completed) |
7904 | 21 | 16.8 | B | May 1996 | H,S |
7929 | 47 | 26.3 | A | May 1996 | R,E,S (not completed) |
7894 | 28 | 17.3 | B | Apr 1996 | None |
7897 | 20 | 13.8 | A | Jan 1996 | R,E,S (not completed) |
7905 | 26 | 18.6 | B | Apr 1996 | S |
7907 | 19 | 14 | B | Dec 1995 | H,S |
7902 | 25 | 19.2 | A | 1995 | H,S (6 mo.) R,E, (7 d) |
5686 | 29 | -- | A | May 1995 | H,R,E,S (not completed) |
5694 | 29 | 17.3 | A | Jan 1995 | H,S (1 mo. in 1995) E,S (1 mo. in 1996) |
5726 | 44 | 16.9 | A | ? | H,R,E,S (3 to 4 mo. in 1991) H,R,E,S (in 1995) |
7911 | 34 | 17.9 | B | Mar 1995 | R,E,S,K |
5688 | 37 | -- | A | Sep 1994 | R,E,S |
5687 | 41 | 20.3 | B | Feb 1996 | E,S |
5729 | 40 | 16.3 | C | 1994 | R,S(3 mo. in 1994) S (in 1996) |
7890 | 19 | -- | A | 1994 | H,E,S (3 mo. in 1994) R,E,S (in 1996) |
5699 | 22 | -- | B | Mar 1996 | H,S |
aGroup A = nonresponders; Group B = new cases (never treated or treated for <1 month); Group C = relapsed cases
bH, isoniazid; R, rifampin; E, ethambutol; S, streptomycin; Z, pyrazinamide; K, kanamycin
cPatient too weak to be weighed